Table 4.
Patients’ outcome
| Characteristic | Patients, No. (%) | P value | ||
|---|---|---|---|---|
| Total (n = 156) |
Period 1 (n = 79) |
Period 2 (n = 77) |
||
| MTL30 | 78 (50.0) | 48 (60.8) | 30 (39.0) | .006* |
| In-hospital mortality | 10 (6.4) | 7 (8.9) | 3 (3.9) | .17 |
| Efficacy of EVT | ||||
| Improvement of leakage | 140 (89.7) | 68 (86.1) | 72 (93.5) | .10 |
| Resolution of leakage | 133 (85.3) | 63 (79.7) | 70 (90.9) | .049* |
| Resolution without additional procedures during or after EVT | 94 (60.3) | 40 (50.6) | 54 (70.1) | .013* |
| Failure-to-cure† | 18 (11.5) | 12 (15.2) | 6 (7.8) | .12 |
| Clavien–Dindo ≥ grade IIIb | 74 (47.4) | 42 (53.2) | 32 (41.6) | .09 |
| CCI, mean (95%CI) | 50.6 (46.8–54.3) | 54.6 (49.3–59.9) | 46.5 (41.3–51.8) | .034* |
| Length-of-stay, median (quartiles), d | 30 (20—53) | 38 (23–60) | 25 (16–44) | .006* |
| Oral nutrition on discharge | 121 (77.6) | 56 (70.9) | 65 (84.4) | .043* |
Values are n (%) unless otherwise indicated
MTL30 in-hospital-mortality or length-of-stay > 30 days; CCI comprehensive complication index;
†Conversion to surgical therapy due to deteriorating leakage during EVT or death
*P < .05